Login / Signup

System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: preliminary experience of a tertiary care institute in India.

Praveen Kumar-MRitin MohindraAshish BhallaNusrat ShafiqVikas SuriDeepa KumariAvaneesh Kumar PandeyAnkur GuptaParul Chawla GuptaAmol N PatilAshish Kumar KakkarSamir Malhotra
Published in: Expert review of anti-infective therapy (2021)
HCQ prophylaxis was found to be safe and well tolerated in HCW when administered after appropriate screening and with monitoring for adverse events.
Keyphrases
  • tertiary care
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus